Hjem › Kronisk fase myeloid leukæmi › Washington
Kronisk fase myeloid leukæmi kliniske forsøg i Washington
3 studier for Kronisk fase myeloid leukæmi søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1136, Edmonds
- Ascentage Investigative Site #1135, Issaquah
- Ascentage Investigative Site #1806, Seattle
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Fred Hutchinson Cancer Research Center, Seattle
- MultiCare Health System Institute, Tacoma
- Northwest Medical Specialties, Tacoma
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 20. jul. 2026 · NCT07091019A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.